Kumpf, Ulrike https://orcid.org/0000-0001-5005-0709
Ezim, Harry
Stadler, Matthias
Burkhardt, Gerrit
Palm, Ulrich
Dechantsreiter, Esther
Padberg, Frank
Funding for this research was provided by:
Ludwig-Maximilians-Universität München (FöFoLe 1106)
Ludwig-Maximilians-Universität München
Article History
Received: 31 October 2022
Accepted: 21 November 2023
First Online: 15 December 2023
Declarations
:
: The study protocol has been approved by the local ethics committee of the Ludwig-Maximilians-University Munich (project-number 21–0731), and the trial is strictly conducted in accordance with the Declaration of Helsinki. During the study, the principal investigator will send changes to the protocol to the Ethics Committee for review and approval, if necessary. A medical study doctor will collect written informed consent from all study participants prior to participation. All data collected will be pseudonymised. The results of this study will be made accessible to scientific researchers and healthcare professionals via publications in peer-reviewed journals.
: Not applicable.
: The authors declare that they have no competing interests.UP has received speaker’s honoraria from neuroCare Group.FP is a member of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel, and the International Scientific Advisory Board of Sooma, Helsinki, Finland. He has received speaker’s honoraria from Mag&More GmbH, the neuroCare Group, Munich, Germany, and Brainsway Inc. His lab has received support with equipment from the neuroCare Group, Mag&More GmbH, and Brainsway Inc.